Literature DB >> 9286620

Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors.

C Montiel1, C J Herrero, E García-Palomero, J Renart, A G García, R B Lomax.   

Abstract

In strips of pig coronary arteries incubated in oxygenated Krebs-bicarbonate solution at 37 degrees C, dotarizine blocked the phasic contractions evoked by 5-HT (0.5 microM) or K+ depolarization (35 mM K+) with an IC50 of 0.22 and 3.7 microM, respectively. Flunarizine inhibited both types of contractions with IC50 values of 1.7 microM for 5-HT and 2.4 microM for K+ responses. In Xenopus oocytes injected with in vitro transcribed RNA encoding for 5-HT2A or 5-HT2C receptors, 5-HT (100 nM for 20 s) applied every 10 min caused, in both cases, a reproducible inward current through Ca2(+)-activated Cl- channels (ICl). Dotarizine inhibited the 5-HT2A response in a concentration-dependent manner, with an IC50 of 2.2 nM. In contrast, the 5-HT2C response was unaffected by 1 microM dotarizine and blocked around 62% by 10 microM of this drug. The ICl activated either by intracellular injection of inositol 1,4,5-trisphosphate (IP3) in oocytes or by direct photorelease of Ca2+ in DM-nitrophen-injected oocytes was unaffected by 10 microM dotarizine. It is concluded that dotarizine blocks 5-HT2A receptors with a high affinity; the compound is devoid of intracellular effects on any further steps of the transduction pathway (i.e., IP3 receptor). Contrary to flunarizine that blocks equally well the serotonergic and the K+ vascular responses, dotarizine exhibits 17-fold higher affinity for vascular 5-HT receptors. These findings might be relevant to an understanding of the mechanism involved in the use of dotarizine and flunarizine as prophylactic agents in migraine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9286620     DOI: 10.1016/s0014-2999(97)01073-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Differential blockade of rat alpha3beta4 and alpha7 neuronal nicotinic receptors by omega-conotoxin MVIIC, omega-conotoxin GVIA and diltiazem.

Authors:  C J Herrero; E García-Palomero; A J Pintado; A G García; C Montiel
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Modulatory mechanism of the endogenous peptide catestatin on neuronal nicotinic acetylcholine receptors and exocytosis.

Authors:  Carlos J Herrero; Eva Alés; Antonio J Pintado; Manuela G López; Esther García-Palomero; Sushil K Mahata; Daniel T O'Connor; Antonio G García; Carmen Montiel
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

3.  The novel Na(+)/Ca(2+) exchange inhibitor KB-R7943 also blocks native and expressed neuronal nicotinic receptors.

Authors:  A J Pintado; C J Herrero; A G García; C Montiel
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

4.  Novel antimigraineur dotarizine releases Ca2+ from caffeine-sensitive Ca2+ stores of chromaffin cells.

Authors:  J Novalbos; F Abad-Santos; P Zapater; J Alvarez; M T Alonso; M Montero; A G García
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

5.  Unmasking the functions of the chromaffin cell alpha7 nicotinic receptor by using short pulses of acetylcholine and selective blockers.

Authors:  M G López; C Montiel; C J Herrero; E García-Palomero; I Mayorgas; J M Hernández-Guijo; M Villarroya; R Olivares; L Gandía; J M McIntosh; B M Olivera; A G García
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.